Twist Bioscience

Twist Bioscience is a California-based DNA synthesis platform that offers solutions including drug discovery and genome editing for sectors such as agriculture and healthcare.

Business Model:

Revenue: $215.8M

Employees: 501-1,000

Detailed Twist Bioscience Information

Geographic Data

Twist Bioscience headquarters map

Address: 681 Gateway Boulevard

City: South San Francisco

State: CA

Zip: 94080

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$250M

Raised Total:

$503M

Metrics

576,752Website Global Rank

77,480Website Monthly Traffic

Twitter Followers

Description

Twist Bioscience is a California-based DNA synthesis platform that offers solutions including drug discovery and genome editing for sectors such as agriculture and healthcare.

Contact Phone:
+18007190671

Contact Email:

Twist Bioscience went public on 10/30/2018 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
10/30/2018

IPO Valuation:
$372M

Ticker Symbol:
TWST

IPO Price:
$14/share

Amount Raised:
$70M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
7/2017 Sphere Fluidics Grant 0
7/2017 Sphere Fluidics Grant 0
Announced Date Transaction Number of Investors Money Raised Lead Investors
1/2016 Series D 13 $61M WuXi Healthcare Ventures
Paladin Capital Group
NanoDimension
Merieux Developpement
Illumina Ventures
GoldenArc Capital
Foresite Capital
Fidelity Management and Research Company
Cormorant Asset Management
Boris Nikolic
2/2014 Series A 3 $9.1M ARCH Venture Partners
Asset Management Ventures (AMV)
Paladin Capital Group
ARCH Venture Partners
Asset Management Ventures (AMV)
6/2017 Venture Round 8 $27M Biomatics Capital Partners
Bay City Capital
Reinet Investments S.C.A.
FIS
Kangmei Pharmaceutical
3W Partners
NFT Investment
Ditch Plains Capital Management LP
Biomatics Capital Partners
Biomatics Capital Partners
Bay City Capital
Reinet Investments S.C.A.
FIS
Kangmei Pharmaceutical
3W Partners
NFT Investment
Ditch Plains Capital Management LP
Biomatics Capital Partners
5/2014 Series B 5 $26M Tao Venture Partners
Paladin Capital Group
NanoDimension
Asset Management Ventures (AMV)
ARCH Venture Partners
Tao Venture Partners
2/2022 Post-IPO Equity 1 $250M Capital World Investors
9/2014 Debt Financing 1 $10M Silicon Valley Bank
6/2015 Series C 9 $37M Illumina
Tao Venture Partners
Paladin Capital Group
NanoDimension
Joby Pritzker
Foresite Capital
Fidelity Management and Research Company
Asset Management Ventures (AMV)
ARCH Venture Partners
Illumina
4/2018 Venture Round $50M
10/2018 IPO $70M
3/2017 Venture Round 2 $33M Asset Management Ventures (AMV)
Dentsu Ventures
Asset Management Ventures (AMV)
Dentsu Ventures
3/2018 Equity $50M
2/2022 Post-IPO Equity $269.4M
12/2020 Post-IPO Equity $323.7M
2/2020 Post-IPO Equity $140M
Announced Date Name Price
11/2021 Abveris
6/2021 iGenomX
4/2016 Genome Compiler

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research